Police will soon be able to orally test drivers for four drugs. But impairment from prescription medications is far more ...
Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.
Merck is buying Cidara Therapeutics for $9.2B, picking up an experimental flu therapy as it looks to broaden its pipeline.
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.
A widely used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according ...
Nearly two dozen babies in 13 states have been sickened in a growing outbreak of infantile botulism linked to recalled ...
This year, I am a junior at North Surry High School and have gotten the opportunity to intern with the Surry County Office of ...
Next year, a multidisciplinary team will begin reviewing fatal overdose cases, examining people's whole lives to find ...
Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh. Who is winning?
MedPage Today on MSN
Vitamin D's Heart Prevention Win; ATTR Depleter Does So-So; Gene Therapy Trial Hold
Personalized vitamin D supplementation -- often requiring 5,000 IU of vitamin D each day -- did prove to have secondary ...
To address the growing concern of substance abuse among students, the Central Board of Secondary Education (CBSE), in ...
Colchicine, a cheap and widely used gout drug, may help prevent heart attacks and strokes in people with cardiovascular disease. Trials involving nearly 23,000 patients show meaningful reductions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results